AXT Q2 Revenue Jumps 77% to $47.6M, Swings to $11.1M Profit on Indium Phosphide Demand
AXTI filed a Earnings and Guidance on elevated volume (1.9× avg).
Summary
AXT reported Q2 2026 revenue of $47.6 million, a 77% sequential increase, and swung to a GAAP net income of $11.1 million as indium phosphide demand for data center optics drove record results.
Key Events · Earnings and Guidance · AXTI
-
Revenue Surges 77% Sequentially
Q2 2026 revenue reached $47.6 million, up from $26.9 million in Q1 2026 and $18.0 million in Q2 2025, driven by record indium phosphide wafer sales for data center optical connectivity.
-
Swings to $11.1M GAAP Profit
GAAP net income was $11.1 million ($0.17 diluted EPS) versus a net loss of $1.6 million in Q1 2026 and $7.0 million in Q2 2025. Non-GAAP net income was $11.9 million ($0.19 per share).
-
Gross Margin Expands to 44.9%
GAAP gross margin improved to 44.9% from 29.6% in Q1 2026 and 8.0% in Q2 2025, reflecting higher volumes, improved productivity, and a favorable product mix.
-
Cash Position Strengthens to $412M
Cash and cash equivalents rose to $412.2 million as of June 30, 2026, from $120.3 million at year-end 2025, providing significant capital for capacity expansion.
Analysis · AXTI · Manufacturing
AXT delivered a breakout quarter, with revenue jumping 77% sequentially to $47.6 million and gross margins expanding to 44.9% from 29.6% in Q1. The company swung from a net loss to an $11.1 million GAAP profit, driven by record indium phosphide revenue tied to data center optical connectivity. This marks a dramatic acceleration from the operational recovery noted in Q1 and validates the capacity investments made over the past year. The balance sheet is flush with $412 million in cash, providing ample runway for further expansion. Against a backdrop of heavy insider selling in June, these results may reassure investors that the business fundamentals are strengthening rapidly.
At the time of this filing, AXTI was trading at $57.02 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $1.85 to $143.16. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.